The shift of the Noncommunicable Diseases (NCDs) epidemic, including cardiovascular disease, from developed to Low and Middle Income Countries (LMIC), creates new challenges in contexts where there is poor information on healthcare costs. Clearly this information is essential for planning, and its relevance is even more valuable as a driver for prevention and control of NCDs. This paper begins to address that handicap by estimating the healthcare cost of Cardiovascular Disease (Coronary Heart Disease and Stroke) in Colombia, using a person-based approach. Results show that the annual healthcare cost of a person with Coronary Heart Disease is between INT$ 4,277 and INT$ 4,846, while the cost for a person with Stroke varies between INT$5,816 ...
Introduction: In USA, each year 5% of Medicare beneficiaries die, accounting for 25% of total Medica...
In addition to the costs of treatment and prevention, diseases generate other types of costs that ar...
In 2005, a global goal of reducing chronic disease death rates by an additional 2% per year was esta...
Objective: The aim is to reflect on the social and economic costs of chronic non-communicable diseas...
Cardiovascular diseases (CVD) are the leading cause of death and burden of disease in Colombia and g...
Noncommunicable diseases (NCDs) are the leading cause of death in the Americas, with cardiovascular ...
Worldwide, more people die from cardiovascular diseases (CVDs) than from any other diseases. Of thes...
Gina Nicholson,1 Shravanthi R Gandra,2 Ronald J Halbert,1 Akshara Richhariya,2 Robert J Nordyke1 1IC...
Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, an...
Background In 2014, 0.3% of the total population in Colombia was living with HIV/AIDS. The data curr...
Objectives This study aimed to estimate the direct medical costs due to hospitalizations by COVID-19...
AbstractObjectiveTo estimate the economic costs of avoidable mortality (AM) in Colombia during the p...
Abstract Background Hypertension represents a high burden of disease in different healthcare systems...
Abstract Background The evidence on the economic burden of cardiovascular disease (CVD) in low- and ...
Abstract Background Coronary artery disease is the most prevalent cardiovascular disease. In the Uni...
Introduction: In USA, each year 5% of Medicare beneficiaries die, accounting for 25% of total Medica...
In addition to the costs of treatment and prevention, diseases generate other types of costs that ar...
In 2005, a global goal of reducing chronic disease death rates by an additional 2% per year was esta...
Objective: The aim is to reflect on the social and economic costs of chronic non-communicable diseas...
Cardiovascular diseases (CVD) are the leading cause of death and burden of disease in Colombia and g...
Noncommunicable diseases (NCDs) are the leading cause of death in the Americas, with cardiovascular ...
Worldwide, more people die from cardiovascular diseases (CVDs) than from any other diseases. Of thes...
Gina Nicholson,1 Shravanthi R Gandra,2 Ronald J Halbert,1 Akshara Richhariya,2 Robert J Nordyke1 1IC...
Background: Chagas disease is one of the leading causes of heart failure (HF) in Latin Americans, an...
Background In 2014, 0.3% of the total population in Colombia was living with HIV/AIDS. The data curr...
Objectives This study aimed to estimate the direct medical costs due to hospitalizations by COVID-19...
AbstractObjectiveTo estimate the economic costs of avoidable mortality (AM) in Colombia during the p...
Abstract Background Hypertension represents a high burden of disease in different healthcare systems...
Abstract Background The evidence on the economic burden of cardiovascular disease (CVD) in low- and ...
Abstract Background Coronary artery disease is the most prevalent cardiovascular disease. In the Uni...
Introduction: In USA, each year 5% of Medicare beneficiaries die, accounting for 25% of total Medica...
In addition to the costs of treatment and prevention, diseases generate other types of costs that ar...
In 2005, a global goal of reducing chronic disease death rates by an additional 2% per year was esta...